Letter to the Editor: Consideration of Neuroimmunological Diseases in Assessments of COVID-19 Vaccination Rates Among Patients With Chronic Medical Conditions

J Korean Med Sci. 2023 Jan 16;38(3):e35. doi: 10.3346/jkms.2023.38.e35.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Chronic Disease
  • Cross-Sectional Studies
  • Humans
  • Vaccination

Substances

  • COVID-19 Vaccines